TRIALS is a dynamic team of researchers aiming to identify new treatments for a range of disorders. Innovation and cross-collaboration are the cornerstones of our research program.
Associate Professor Olivia Dean
Director, IMPACT Trials
About our work
IMPACT TRIALS works with collaborators both nationally and internationally. There have been a number of completed trials with agents including; N-acetyl cysteine, minocycline, mitochondrial enhancers, asprin, and rosuvastatin. Data from these trials provides rich sources to explore not only primary efficacy but also underlying factors related to treatment response.
TRIALS ultimately aims both to provide interventions that can be rolled out into clinical practice and to identify factors that will enhance personalised medicine in psychiatry
Studies
See below our upcoming, current and past studies at IMPACT TRIALS
Caring about return to work after a stroke
Open
Returning to work after stroke in rural communities
Open
BipolarASSIST: A new program for family and friends of people with bipolar disorder
Open
BipolarWISE: A new program about living well with bipolar disorder
Open
RESET (Resuming Employment after Stroke- Enhancement through Telecoordination) Advisory Network
Open
Coping with COVID-19
Closed
RESET: Resuming Employment after Stroke: Enhancement through Telecoordination
Open
DepressionASSIST: Psychoeducation website for close family friends of adults with major depressive disorder
Open
CADET-UD Trial: Candesartan for major depressive disorder
Open
CADET-BD Trial: Candesartan for bipolar disorder
Open
Mangosteen trial: Mangosteen for bipolar depression
Closed